Pancreatic cancer stemness: dynamic status in malignant progression

Area of Science:

• Oncology
• Cancer Biology
• Stem Cell Research

Background:

• Pancreatic cancer (PC) is a highly aggressive malignancy with poor patient outcomes.
• Pancreatic cancer stem cells (PCSCs) are implicated in therapeutic resistance, metastasis, and recurrence.
• The plasticity and self-renewal of PCSCs present significant challenges to current treatment modalities.

Purpose of the Study:

• To review the regulatory mechanisms governing pancreatic cancer stem cells (PCSCs).
• To explore the role of stemness-related signaling pathways and the tumor microenvironment (TME) in PCSC regulation.
• To discuss innovative stemness-targeted therapies for pancreatic cancer.

Main Methods:

• Literature review focusing on pancreatic cancer stem cell biology.
• Analysis of stemness-related signaling pathways and their regulation.
• Examination of the tumor microenvironment's influence on PCSCs.
• Review of emerging stemness-targeted therapeutic strategies.

Main Results:

• PCSCs exhibit high plasticity and self-renewal capacities, contributing to PC aggressiveness.
• Stemness-related signaling pathways and TME components critically regulate PCSC behavior.
• Understanding these regulatory mechanisms is key to overcoming therapeutic resistance.

Conclusions:

• Targeting PCSC plasticity and self-renewal is crucial for effective pancreatic cancer treatment.
• Novel therapeutic strategies should focus on inhibiting stemness pathways and modulating the TME.
• Further research into PCSC biology will pave the way for improved patient survival rates.